Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.7825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Xiarepati Tieliwaerdi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Apixaban dosing in atrial fibrillation/atrial flutter (AF/AFL) may not consistently follow dose-reduction criteria in routine care.
Objective
To perform a quality improvement (QI) analysis of apixaban prescribing in AF/AFL and identify factors associated with inappropriate dose reduction or failure to reduce dose when indicated.
Methods
We analyzed 179,705 deidentified anticoagulation records from January 1, 2022, to October 15, 2024. Patients were included if diagnoses contained AF/AFL and at least 1 record contained apixaban. To preserve longitudinal follow-up while limiting duplicate same-day ordering and reconciliation artifacts, we retained 1 apixaban record per patient per day and kept the latest order that day. Records for thrombus treatment were excluded. For each patient-day record, the nearest prior creatinine within 365 days was matched. Dose reduction was indicated when at least 2 criteria were present: age >=80 years, weight =1.5 mg/dL. Mixed-effects logistic regression with patient random intercept was the primary analysis.
Results
Among 1000 included patients, 98,970 patient-day apixaban records met analytic criteria. Of these, 80,286 (81.1%) were appropriately dosed, 13,830 (14.0%) were inappropriately reduced to 2.5 mg, and 3,792 (3.8%) met reduction criteria but remained on 5 mg; 43 records were unassessable and excluded from comparative modeling. In mixed-effects models, inappropriate reduction to 2.5 mg was associated with surgical specialty versus cardiology (OR 6.55, 95% CI 6.17-6.94, p
Zitieren
APA
Tieliwaerdi, X., Sheth, A., Bagheri, M., Wert, Y., & Garton, A. (2026). Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7825
Vancouver
Tieliwaerdi X, Sheth A, Bagheri M, Wert Y, Garton A. Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7825
BibTeX
@article{Tieliwaerdi2026,
author = {Tieliwaerdi, Xiarepati and Sheth, Aakash and Bagheri, Marziyeh and Wert, Yijin and Garton, Alex},
title = {Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.7825}
}
EUVIMED